Oct 10, 2026 from The Cancer News PD-L1 Alone Isn't Enough, and Neither Is TMB: What Would a Real Immunotherapy Biomarker Look Like? Explore immunotherapy biomarker updates: PD-L1 limits, TMB CheckMate 227 trials, HLA and ctDNA models, and prospective machine-learning scores.
Oct 09, 2026 from The Cancer News Two Advances Are Reshaping Bladder Cancer Care Before and After Surgery Explore muscle-invasive bladder cancer updates: perioperative EV-Pembro approval, KEYNOTE-B15 data, and IMvigor011 ctDNA-guided adjuvant therapy.
Oct 09, 2026 from Your Local Epidemiologist The revolutionary art of fixing the thing people are complaining about Project Stethoscope, potholes, and everything in between
Oct 07, 2026 from The Cancer News Surgery or Radiation for Stage III Lung Cancer? The Better Question Is Not Which, But When Do We Decide Explore Stage III NSCLC updates: PACIFIC durvalumab data, neoadjuvant chemo-immunotherapy conversion rates, and multidisciplinary surgical timing.
Oct 07, 2026 from The Cancer News ER-Positive Breast Cancer in 2026: New Oral Endocrine Agents and the Case for ctDNA-Guided Switching Explore ER+ breast cancer updates: lidERA giredestrant data, vepdegestrant PROTAC approvals, and SERENA-6 ctDNA-guided treatment switching.
Oct 07, 2026 from The Cancer News A Rare Liver Cancer in a Young Woman Underscores the Need for More Options Explore fibrolamellar carcinoma updates: DNAJB1-PRKACA fusion insights, STRIDE regimen challenges, and gemcitabine-oxaliplatin plus lenvatinib care.
Oct 07, 2026 from Your Local Epidemiologist Top 8 questions about the “plague” situation Well, “the plague” is trending on almost all social media channels now.
Oct 06, 2026 from Your Local Epidemiologist Plague in Russia? Plus flu, common cold, a new opioid, and good news The Dose (October 6)
Oct 05, 2026 from The Cancer News Targeting Endocrine Resistance: New Sequencing Strategies in Metastatic Breast Cancer Explore metastatic breast cancer updates: ESR1 oral SERDs, vepdegestrant PROTAC data, PI3K/AKT inhibitors, and ctDNA-guided early switching.
Oct 05, 2026 from The Cancer News Combining Immunotherapy With Local Treatment Advances Liver Cancer Care, While a Provocative New Question Emerges About Diabetes Drugs Explore liver cancer updates: EMERALD-3 TACE plus STRIDE data, TARE practice patterns, and GLP-1 receptor agonist signals in solid tumor control.
Oct 01, 2026 from The Cancer News Advances in the Management of Lung Cancer in 2025 and 2026 Explore key advances in SCLC and NSCLC management, including drug approvals, bispecific T-cell engagers, antibody-drug conjugates, and targeted therapies.
Sep 30, 2026 from The Cancer News Leptomeningeal Disease Is Becoming More Common, and Also More Treatable Explore leptomeningeal disease updates: EGFR/ALK targeted therapies, NCCN CSF ctDNA testing guidelines, and proton craniospinal irradiation.
Sep 30, 2026 from Your Local Epidemiologist When “DEI” research is cut, what happens to community health? Health equity is caught in the crossfire
Sep 29, 2026 from Your Local Epidemiologist Flu is here early. Plus Covid, mosquitoes, and more. The Dose (Sept 29)
Sep 28, 2026 from The Cancer News Sequencing CAR-T and Bispecific Antibodies in Multiple Myeloma: What the Data Show Explore multiple myeloma updates: CAR-T vs. bispecific sequencing, T-cell exhaustion factors, IVIG infection prophylaxis, and dual-antigen strategies.
Sep 25, 2026 from Your Local Epidemiologist Don’t boil the ocean: Reach passive positives The 2026 fall vaccines should be available, for free, to everyone who needs them.
Sep 23, 2026 from Your Local Epidemiologist Medicare for All: Separating the slogan from the substance People are fed up with the U.S.
Sep 22, 2026 from Your Local Epidemiologist Where are the fall vaccines? Plus Covid-19 and norovirus, and what another measles death means The Dose (Sept 22)
Sep 21, 2026 from The Cancer News At-Home Cervical Cancer Screening Kits Outperform Office-Based Approach in Under-Resourced Settings New research from MD Anderson finds mailed HPV screening kits more effective than clinic-based exams, offering a game-changing solution to reduce cervical cancer disparities in underserved and glob...
